- ASCS transplantation demonstrated superior and durable repigmentation outcomes in stable vitiligo.
- The study compared ASCS treatment with narrow-band ultraviolet B (NB-UVB) monotherapy.
- ASCS treatment was found to be safe and effective, providing favorable cosmetic outcomes.
- The study involved a U.S. multicenter, randomized, within-subject controlled trial with 25 participants.
- 40% of ASCS-treated lesions maintained 80% or more repigmentation through week 52.
- Limitations of the study include a small sample size and lack of diversity in participants' skin types and racial backgrounds.
- Future research should aim to increase the sample size and evaluate combined use of ASCS with other medical and phototherapeutic treatments.
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
